Mark Lappe 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-26 4:16 pm Purchase | 2024-09-12 | 13D | Inhibrx Biosciences, Inc. INBX | Mark Lappe | 925,413 6.400% | 164,000 (+21.54%) | Filing |
| 2024-06-03 8:43 pm Purchase | 2024-05-29 | 13D | Inhibrx Biosciences, Inc. INBX | Mark Lappe | 761,413 5.260% | 761,413 (New Position) | Filing |